Replimune to Present at Two Upcoming Investor Conferences

Rhea-AI Summary

Replimune (Nasdaq: REPL) said its management team will present at two investor conferences in March 2026: a fireside chat at the Leerink Partners 2026 Global Healthcare Conference on March 9, 2026 at 2:20 pm EDT, and 1x1 meetings at the Jefferies 2026 Biotech on the Beach Summit on March 10, 2026.

Live webcast of the March 9 fireside chat will be available in the Investors section of Replimune's website, with a replay available for 30 days after the conference.

News Market Reaction – REPL

-6.41%

14 alerts

-6.41% News Effect

-2.4% Trough in 1 hr 17 min

-$41M Valuation Impact

$595M Market Cap

0.4x Rel. Volume

On the day this news was published, REPL declined 6.41%, reflecting a notable negative market reaction. Argus tracked a trough of -2.4% from its starting point during tracking. Our momentum scanner triggered 14 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $41M from the company's valuation, bringing the market cap to $595M at that time.

Data tracked by StockTitan Argus on the day of publication.

WOBURN, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that members from the Replimune management team will present and host investor meetings at the following two conferences:

Leerink Partners 2026 Global Healthcare Conference
Date: Monday, March 9, 2026
Fireside Chat Time: 2:20 pm EDT

Jefferies 2026 Biotech on the Beach Summit
Date: Tuesday, March 10, 2026
1x1 Meetings

Live webcasts of the fireside chat will be available in the Investors section of Replimune’s website at www.replimune.com. A replay will be available for 30 days following the conference.

About Replimune
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of novel oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is intended to ignite local activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to then activate a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.

Investor Inquiries
Chris Brinzey
ICR Healthcare
339.970.2843
chris.brinzey@icrhealthcare.com 

Media Inquiries
Arleen Goldenberg
Replimune
917.548.1582
media@replimune.com 

FAQ

When is Replimune (REPL) presenting at the Leerink Partners 2026 Global Healthcare Conference?

Replimune will present at Leerink Partners on Monday, March 9, 2026 with a fireside chat at 2:20 pm EDT. According to Replimune, the fireside chat will be webcast live via the company's Investors webpage and a replay will be available for 30 days.

What is Replimune's (REPL) schedule for Jefferies 2026 Biotech on the Beach Summit?

Replimune management will hold 1x1 investor meetings on Tuesday, March 10, 2026 at Jefferies Biotech on the Beach. According to Replimune, these are scheduled investor meetings rather than a public fireside chat and will occur the day after the Leerink presentation.

Will the Leerink fireside chat for Replimune (REPL) be available to watch online?

Yes, the Leerink fireside chat will be webcast live and made available online. According to Replimune, the live webcast is on the company's Investors section and a replay will remain accessible for 30 days after the conference.

How long will the replay of Replimune's (REPL) March 9 fireside chat be available?

The replay will be available for 30 days following the conference. According to Replimune, investors can view the replay via the Investors section of the company's website during that 30-day period.

Where can investors access Replimune (REPL) webcasts and replay materials for the March 2026 conferences?

Investors can access webcasts and replays on Replimune's Investors webpage at www.replimune.com. According to Replimune, the March 9 fireside chat will be webcast live there and the replay will be posted for 30 days.